[Ip-health] Médecins Sans Frontières (MSF) submission to the 2020 USTR Special 301 Review Process

Roshan JOSEPH Roshan.JOSEPH at geneva.msf.org
Fri Feb 7 01:04:22 PST 2020

The United States Trade Representative's (USTR) had called for comments from stakeholders for their 2020 Special 301 Report. The Special 301 report is an annual report by the USTR that names countries on watch lists, in line with its powerful pharmaceutical industry, for making use of public health safeguards in intellectual property laws.
Médecins Sans Frontières (MSF)/Doctors Without Borders have submitted their comments to the review process and raised concerns of the public health impact of this practice. MSF has recommended the USTR to refrain from listing countries on the Special 301 watchlists for making use of flexibilities available under the TRIPS agreement to promote access to medicines for all. MSF has further made note of the USTR's recent visit to India for a potential trade deal and has urged not to pursue damaging policies that are aimed at changing the country's pro-access intellectual property and regulatory laws.
The USTR's approach towards continuously raising standards of intellectual property is a hindrance in addressing the global problem of excessive pricing of pharmaceutical products in developed and developing countries.
The submissions of MSF is attached herewith.

More information about the Ip-health mailing list